Home
Live Updates
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript : comparemela.com
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75.
Related Keywords
Rhode Island ,
United States ,
Italy ,
Sweden ,
Spain ,
Germany ,
Tolga Tanguler ,
Raymond James ,
Maury Raycroft ,
Pushkal Garg ,
Gary Nachman ,
Jeff Poulton ,
Christine Lindenboom ,
Paul Matteis ,
David Lebowitz ,
Yvonne Greenstreet ,
Alnylam Pharmaceuticals Quarter ,
Corporate Communications At Alnylam ,
Alnylam Pharmaceuticals Inc ,
Nasdaq ,
Alnylam Pharmaceuticals ,
Call Transcript May ,
Alnylam Pharmaceuticals Quarter One ,
Senior Vice President ,
Investor Relations ,
Corporate Communications ,
Chief Executive Officer ,
Chief Commercial Officer ,
Chief Medical Officer ,
Chief Financial ,
Safe Harbor ,
Private Securities Litigation Reform Act ,
Thanks Tolga ,
Budget Film Locations ,
comparemela.com © 2020. All Rights Reserved.